[Increased autoaggression caused by cholesterol lowering drugs?].
作者信息
Richter W O
机构信息
Medizinische Klinik II, Universität München.
出版信息
Fortschr Med. 1994 Dec 20;112(35-36):507-8.
PMID:7843681
Abstract
摘要
相似文献
1
[Increased autoaggression caused by cholesterol lowering drugs?].[降胆固醇药物会导致自身攻击性增强吗？]
Fortschr Med. 1994 Dec 20;112(35-36):507-8.
2
Deaths due to accidents and violence in two recent trials of cholesterol-lowering drugs.在最近两项降胆固醇药物试验中因意外和暴力导致的死亡情况。
Arch Intern Med. 1990 Oct;150(10):2169-72.
3
Cholesterol lowering and morbidity and mortality.
Curr Opin Lipidol. 1995 Feb;6(1):62-5.
4
Cholesterol and violent behavior.胆固醇与暴力行为。
Arch Intern Med. 1994 Jun 27;154(12):1317-21.
5
[Preventing infarct by lowering LDL. Is 100 the upper limit for every diabetic patient?].
MMW Fortschr Med. 2003 Sep 18;145(38):60.
6
[Hypercholesterolemia in high risk patients. Targeting low goal values].[高危患者的高胆固醇血症。设定低目标值]
MMW Fortschr Med. 2001 Apr 12;143(15):50-1.
7
Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.降胆固醇治疗的前景：依折麦布（一种新型肠道胆固醇吸收选择性抑制剂）的作用
Circulation. 2003 Jul 1;107(25):3124-8. doi: 10.1161/01.CIR.0000072345.98581.24.
8
9
Profiling a landmark clinical trial: Scandinavian Simvastatin Survival Study.
Curr Opin Lipidol. 1995 Oct;6(5):251-3.
10
Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality.肾移植功能障碍——与心血管疾病和死亡的传统风险因素相比，其重要性得到量化。
Nephrol Dial Transplant. 2006 Aug;21(8):2282-9. doi: 10.1093/ndt/gfl095. Epub 2006 Mar 30.
Zotero 插件